Longitudinal study on neuropathic pain and its effects on brain function
Official title: A Multi-center Clinical Longitudinal Study of Neuropathic Pain by Collecting Data on Patients' Brain Physiology and Cognitive Function
Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT06290024 · Data updated 2026-11-12
This study is trying to see how living with neuropathic pain affects brain function and thinking over time in people who experience it.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 1 site (Shanghai, Yangpu) |
| Status | Recruiting |
| Started | August 15, 2023 |
| Main results expected | July 15, 2025 |
| Study ends | July 15, 2025 |
| Registry record updated | November 13, 2024 |
| Trial ID | NCT06290024 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 85 who have clinically diagnosed neuropathic pain with a pain score of 4 or higher.
✕Probably not a fit
Patients who do not have neuropathic pain or have participated in other drug or medical device trials within the last three months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect data on patients experiencing neuropathic pain by assessing various factors including brain physiology and cognitive function. Participants will undergo a series of evaluations using pain scales, cognitive assessments, and brain imaging techniques such as EEG and fNIRS. The study will track dynamic changes in these factors over time to better understand the relationship between pain and cognitive processes. By gathering comprehensive data, the study seeks to provide insights into the complexities of neuropathic pain.
Why it matters
Potential benefit: If successful, this study could enhance understanding of neuropathic pain and lead to improved management strategies for patients.
How similar studies have gone: While there have been studies on neuropathic pain, this specific approach of combining multiple assessment methods in a longitudinal design is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The subjects voluntarily participated in the study and signed an informed consent form; 2. The age is between 18 years old (inclusive) and 85 years old (inclusive), regardless of gender; 3. Body mass index (BMI) ≤ 45; 4. Clinically clearly diagnosed neuropathological pain (pain VAS score ≥4 or above); 5. Did not participate in the drug/medical device test within 3 months before the test; Exclusion Criteria: \-
Where it's running
-
Ke Ma
Shanghai, Yangpu, China Recruiting
Study contacts
- Study coordinator: jingting chen, phd
- Email: 806041409@qq.com
- Phone: 13122778387
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.